Zhejiang Dayang Biotech Group Co (SHE:003017) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang Dayang Biotech Group Co (003017)
Zhejiang Dayang Biotech Group Co (SHE:003017) has a market capitalization of $394.81 Million (CN¥2.70 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #13754 globally and #4333 in its home market, demonstrating a 1.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Dayang Biotech Group Co's stock price CN¥32.12 by its total outstanding shares 84000000 (84.00 Million). Analyse 003017 cash flow conversion to see how efficiently the company converts income to cash.
Zhejiang Dayang Biotech Group Co Market Cap History: 2020 to 2026
Zhejiang Dayang Biotech Group Co's market capitalization history from 2020 to 2026. Data shows growth from $416.37 Million to $394.81 Million (3.07% CAGR).
Zhejiang Dayang Biotech Group Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Dayang Biotech Group Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.25x
Zhejiang Dayang Biotech Group Co's market cap is 0.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.59x
Zhejiang Dayang Biotech Group Co's market cap is 3.59 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $416.37 Million | $678.34 Million | $91.61 Million | 0.61x | 4.55x |
| 2021 | $341.48 Million | $783.21 Million | $70.01 Million | 0.44x | 4.88x |
| 2022 | $230.68 Million | $1.06 Billion | $80.73 Million | 0.22x | 2.86x |
| 2023 | $290.22 Million | $919.45 Million | $50.01 Million | 0.32x | 5.80x |
| 2024 | $228.87 Million | $909.96 Million | $63.75 Million | 0.25x | 3.59x |
Competitor Companies of 003017 by Market Capitalization
Companies near Zhejiang Dayang Biotech Group Co in the global market cap rankings as of May 4, 2026.
Key companies related to Zhejiang Dayang Biotech Group Co by market ranking:
- BASF SE (F:BASA): Ranked #536 globally with a market cap of $49.38 Billion USD ( €42.24 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #575 globally with a market cap of $45.45 Billion USD ( €38.87 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #802 globally with a market cap of $32.94 Billion USD ( CN¥225.13 Billion CNY).
- Hengli Petrochemical Co Ltd (SHG:600346): Ranked #1121 globally with a market cap of $22.75 Billion USD ( CN¥155.49 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #536 | BASF SE | F:BASA | $49.38 Billion | €13.80 |
| #575 | BASF SE | XETRA:BAS | $45.45 Billion | €54.74 |
| #802 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $32.94 Billion | CN¥30.70 |
| #1121 | Hengli Petrochemical Co Ltd | SHG:600346 | $22.75 Billion | CN¥22.09 |
Zhejiang Dayang Biotech Group Co Historical Marketcap From 2020 to 2026
Between 2020 and today, Zhejiang Dayang Biotech Group Co's market cap moved from $416.37 Million to $ 394.81 Million, with a yearly change of 3.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥394.81 Million | +7.57% |
| 2025 | CN¥367.03 Million | +60.37% |
| 2024 | CN¥228.87 Million | -21.14% |
| 2023 | CN¥290.22 Million | +25.81% |
| 2022 | CN¥230.68 Million | -32.45% |
| 2021 | CN¥341.48 Million | -17.99% |
| 2020 | CN¥416.37 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Zhejiang Dayang Biotech Group Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $394.81 Million USD |
| MoneyControl | $394.81 Million USD |
| MarketWatch | $394.81 Million USD |
| marketcap.company | $394.81 Million USD |
| Reuters | $394.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium carbonate and chloride, ammonium chloride, and bicarbonate food and feed additives; industrial grade potassium carbonate and bicarbonate; and agricultural and industrial grade ammonium chloride. It also provide… Read more